Phase I/II Clinical Trial of Autologous Activated Platelet-Rich Plasma (aaPRP) in the Treatment of Severe Coronavirus Disease 2019 (COVID-19) Patients

Phase I/II Clinical Trial of Autologous Activated Platelet-Rich Plasma (aaPRP) in the Treatment of Severe Coronavirus Disease 2019 (COVID-19) Patients

Background. The outbreak of Coronavirus Disease 2019 (COVID-19) has been increasing rapidly. This disease causes an increase in proinflammatory cytokine production that leads to cytokine storm or cytokine release syndrome (CRS). Autologous activated platelet-rich plasma (aaPRP) contains various type...

Full description

Saved in:
Bibliographic Details
Main Authors: Karina Karina, Iis Rosliana, Imam Rosadi, Siti Sobariah, Louis Martin Christoffel, Rita Novariani, Siti Rosidah, Novy Fatkhurohman, Yuli Hertati, Nurlaela Puspitaningrum, Wismo Reja Subroto, Irsyah Afini, Difky Ernanda
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:International Journal of Inflammation
Online Access:http://dx.doi.org/10.1155/2021/5531873
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://dx.doi.org/10.1155/2021/5531873

Similar Items